Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 147, Issue 1, 2009, Pages 57-60

  Vural, Pervin ^a   Küskü Kiraz, Zeynep ^a   Doǧru Abbasoǧlu, Semra ^a   Çil, Esra ^b   Karadaǧ, Berrin ^b   Akgül, Cemil ^a   Uysal, Müjdat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Polycystic ovary syndrome; Polymorphism; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 71849094749     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.06.026     Document Type: Article

References (33)

1. Assuncion M., Cavla R.M., San Millan I.L., Sancho J., Avila S., and Escobar-Moreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
2. Sam S., and Dunaif A. Polycystic ovary syndrome: syndrome XX?. Trends Endocrinol Metab 14 (2003) 365-370
3. Franks S., Gharani N., Waterworth D., et al. The genetic basis of polycystic ovary syndrome. Hum Reprod 12 (1997) 2541-2548
4. Legro R.S. The genetics of polycystic ovary syndrome. Am J Med 98 IA (1995) 9S-16S
5. Geva E., Jaffe R.B., and Edward W.E. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 424-438
6. Agrawal R., Sladkevicius P., Engmann L., et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 13 (1998) 651-655
7. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., and Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146 (1995) 157-165
8. Alem F.A., and Pridanic M. Transvaginal color Doppler determination of uterine blood flow characteristics in PCOD. Fertil Steril 6 (1996) 515-516
9. Patel S.R., and Korytkowski M.T. Polycystic ovary syndrome: how best to establish the diagnosis. Women Health Prim Care 3 (2000) 55-69
10. Vincenti V., Cassano C., Rocchi M., and Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93 (1996) 1493-1495
11. Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12 (2000) 1232-1235
12. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 (2002) 260-264
13. Stevens A., Soden J., Brenchley P.E., Ralph S., and Ray D.W. Haplotype analysis of the polymorphic vascular endothelial growth factor gene promoter. Cancer Res 63 (2003) 812-816
14. Berse B., Brown L.F., Van De Water L., Dvorak H.F., and Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3 (1992) 211-220
15. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
16. Nagy B., Savli H., Molvarec A., et al. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Clin Chim Acta 389 (2008) 126-131
17. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
18. Lee A., Christenson L.K., Patton P.E., Burry K.A., and Stouffer R.L. Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum Reprod 12 (1997) 2756-2761
19. Artini P.G., Fasciani A., Monti M., Luisi S., D'Ambrogio G., and Gennazzani A.R. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70 (1998) 560-564
20. Agrawal R., Tan S.L., Wild S., et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 71 (1999) 287-293
21. Van Blerkom J., Antezak M., and Schrader R. The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 12 (1997) 1047-1055
22. Amin A.F., Abdel-Aal D.E., Darwish A.M., and Meki A.R. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome. Fertil Steril 79 (2003) 938-941
23. Artini P.G., Monti M., Matteucci C., Valentino V., Cristello F., and Genazzani A.R. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol Endocrinol 22 (2006) 465-470
24. McClure N., Healy D.L., Rogers P.A., et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344 (1994) 235-236
25. Krasnow J.S., Berga S.L., Guzick D.S., Zeleznik A.J., and Yeo K.T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 65 (1996) 552-555
26. Akiri G., Nahari D., Finkelstein Y., Le S.-Y., Elroy-Stein O., and Levi B.-Z. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17 (1998) 227-236
27. Banyasz I., Szabo S., Bokodi G., et al. Genetic polymorphisms of vascular endothelial growth factor in severe preeclampsia. Mol Hum Reprod 12 (2006) 233-236
28. Kim S.H., Choi Y.M., Choung S.H., Jun J.K., Kim J.G., and Moon S.Y. Vascular endothelial growth factor gene +405C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 20 (2005) 2904-2908
29. Hsieh Y.Y., Chang C.C., Tsai F.J., Yeh L.S., Lin C.C., and Peng C.T. T allele for VEGF gene -460 polymorphism at the 5′-untranslated region: association with a higher susceptibility to endometriosis. J Reprod Med 49 (2004) 468-472
30. Hefler L.A., Mustea A., Könsgen D., et al. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res 13 (2007) 898-901
31. Jacobs E.J., Feigelson H.S., Bain E.B., et al. Pooymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8 (2006) R22
32. Lee E.J., Oh B., Lee J.Y., Kimm K., Park J.M., and Baek K.H. Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome. Fertil Steril 89 (2008) 1751-1759
33. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936C/T mutation in the gene of vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443-447